Cardiff Oncology
CRDF
37 hedge funds and large institutions have $936K invested in Cardiff Oncology in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 6 closing their positions.
17% more capital invested
Capital invested by funds: $797K → $936K (+$139K)
0% less ownership
Funds ownership: 0.07% → 0.07% (-0%)
3% less funds holding
Funds holding: 38 → 37 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.1K |
| 2 |
Renaissance Technologies
New York
|
+$44.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.3K |
| 4 |
VF
Virtu Financial
New York
|
+$11.7K |
| 5 |
Jane Street
New York
|
+$4.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$34K |
| 2 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
-$26K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$25K |
| 4 |
Bank of New York Mellon
New York
|
-$8.41K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $1K | -$616 | -25 | -30% |
|
|
BWA
27
BDO Wealth Advisors
Jacksonville,
Florida
| $1K | -$518 | -21 | -50% |
|
|
AG
28
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
IA
29
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
IP
30
Intellectus Partners
San Francisco,
California
| $1K | – | – | – |
|
31
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
32
BNP Paribas Financial Markets
Paris,
France
| $7 | – | – | – |
|
|
33
Millennium Management
New York
| – | -$34K | -1,547 | Closed |
|
|
CGA
34
Crescent Grove Advisors
Lake Forest,
Illinois
| – | -$26K | -1,194 | Closed |
|
|
TSS
35
Two Sigma Securities
New York
| – | -$25K | -1,134 | Closed |
|
|
36
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$7K | -297 | Closed |
|
37
Citigroup
New York
| – | -$1K | -28 | Closed |
|
|
TWA
38
TCI Wealth Advisors
Tucson,
Arizona
| – | -$74 | -3 | -75% |
|
39
Wells Fargo
San Francisco,
California
| – | +$173 | +7 | New |
|
40
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$542 | +22 | +440% |
|
CRDF Hedge Fund Activity: Q1 2018 in Review
37 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2018, worth a combined $936K — up 17% from $797K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CRDF and 5 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $72.1K. The largest seller was Millennium Management, exiting entirely with an estimated $34K sold.
- 37 institutional investors held Cardiff Oncology (CRDF) as of Q1 2018, down from 38 in Q4 2017.
- Funds reported $936K of Cardiff Oncology stock for Q1 2018, up 17% quarter-over-quarter.
- 5 funds opened new Cardiff Oncology positions in Q1 2018 and 6 closed out, a net change of -1 holder.
- The largest Cardiff Oncology buyer in Q1 2018 was Vanguard Group, an estimated $72.1K added.
- The largest Cardiff Oncology seller in Q1 2018 was Millennium Management, an estimated $34K sold.
Based on aggregated 13F filings for Q1 2018.